请输入您要查询的百科知识：

　

词条 Regional Leishmaniasis Control Center
释义

  1. Objectives[1]

  2. Integrated programs[1]

  3. Publications

  4. References

  5. External links

{{orphan|date=February 2015}}{{Infobox company
|name = Regional Leishmaniasis Control Center (RLCC)
| native_name = المركز الاقليمي لمكافحة الليشمانيا
| native_name_lang = Arabic
| trading_name = RLCC
|logo =Regional Leishmaniasis Control Center RLCC logo.jpg
| founder = Dr. Mohamed Ahmed Al-Kamel (MD)
| area_served = Yemen Republic, Middle East & World wide
|key_people = Dr. Mohamed A. Al-Kamel (MD), President
|industry = Professional - Health Agency · Community Organization
| brands = YemenLeish Newsletter, Medicine-For-All program, "insuring medicine for the poor"
| services = Consultation, Lab Diagnosis, Management, Treatment, Medicine Donation, Rehabilitation, Follow-up, Child Care, Surveillance, Research, Prevention, Disease Control, Education, Medical Camps, Remote Field Visits, Meetings and Workshops, Community Partnership
|revenue =
| divisions = Sana'a Governorate Unit, Al Baydaa Governorate Unit, Hajjah Governorate Unit, IbbGovernorate Unit, Taiz Governorate Unit, Dhamar Governorate Unit, .. ..
|foundation = Yemen (2013)
|location_city =
Sana'a
|location_country = Yemen
|homepage = {{url|http://www.rlccye.org}}
}}

The Regional Leishmaniasis Control Center (RLCC) is 501(c)(3) non-profit charity dedicated to control and eradicate the neglected endemic leishmaniasis disease from Yemen. It currently has 4 regional centers with its headquarter in Sana'a; the capital city of Yemen.[1][2][2]

RLCC was founded during April, 2013 by the Yemeni dermatologist and ISD's member; Dr. Mohamed Ahmed Al-Kamel (MD), in collaboration with the American Academy of Dermatology (AAD), International Society of Dermatology (ISD) and International League of Dermatological Societies (ILDS).[3][4][5][6][7][8]

Eradication of Leishmaniasis from Yemen Project (ELYP) is the main project of the RLCC, and Medicine-For-All Program that insures medicine for the poor is its principal program (in partnership with Stiefel/GSK). The Board of Trustees is the principal authority of the foundation, and a widely growing network of volunteers, including physicians, scientists, technicians, health workers, community leaders, and patients support its integrated programs.[9][1][7]

Objectives[1]

The main objectives of RLCC include:

(1) Integrating leishmaniasis diagnostic and management educational programs for physicians, technicians and health workers and train them how to carry out early detection of cases and to enable them to treat/refer patients with leishmaniasis to our centers.

(2) Increasing education and community awareness about the disease and preventive actions.

(3) Geo-Location of the affected populations and creating an epidemiological profile for leishmaniasis disease in Yemen.

(4) Improving the quality of the diagnosis of human and animal Leishmaniasis, unraveling the genome of the causative agents through, and exploring means to reduce the risk of this disease and improve the treatment strategies.

(5) Providing patients, with all available treatment and preventive options.

(6) Supporting leishmaniasis-related research capabilities.

Integrated programs[1]

1. RLCC Construction and Development Program

2. Community Education Program

3. Surveillance Program

4. Medicine-For-All Program "insuring medicine for the poor"

5. Vector-Reservoir Control Program

6. Research Program

7. Teledermatology Program[10]

8. Field Campaigns

9. Rehabilitation Program

Publications

- YemenLeish (ISSN: 2518-9875) is the official, printed, periodical newsletter of the Regional Leishmaniasis Control Center (RLCC).
  • YemenLeish Vol. 4, No. 1, Summer 2016.[11]
  • YemenLeish Vol. 5, No. 1, Winter 2016-2017.[12]
- Leishmaniasis in Yemen: a clinicoepidemiological study of leishmaniasis in central Yemen.[13]- Spectrum of winter dermatoses in rural Yemen.[14]- Impact of leishmaniasis in women: a practical review with an update on my ISD-supported initiative to LYP).[15]- Stigmata in cutaneous leishmaniasis: Historical and new evidence-based concepts.[16]- Feasibility of teledermatology in the eradication of leishmaniasis from Yemen project.[10]- Cutaneous T Cell Lymphoma (CTCL) Superimposed on Disseminated Cutaneous Leishmaniasis (DCL) in an Immunocompromised Female from Yemen.[17]- Leishmaniasis and malignancy: A review and perspective.[18]

References

1. ^1 2 3 RLCC & ELYP, RLCCye.org.
2. ^{{Cite journal|last=Abdul-Ghani|first=Rashad|date=2017-01-17|title=Combat against Neglected Parasitic Diseases in Yemen: The Need for Mapping as a Prerequisite for Elimination|url=https://www.ust.edu/ojs/index.php/yjmp/article/view/1087/1142|journal=Yemeni Journal for Medical Sciences|language=en|volume=10 |pages=1–5|doi=10.20428/YJMS.10.1.E|issn=2227-961X}}
3. ^{{Cite journal|last=American Academy of Dermatology|first=AAD, Community, Corporate, and Philanthropic Relations|date=Spring 2014|title=GLOBAL COMMUNITY: A grant was also awarded to Mohamed Al-Kamel, MD, to help with efforts at the Regional Leishmaniasis Control Center in Yemen|url=https://www.aad.org/File%20Library/Global%20navigation/Top%20utility%20navigation/Support%20AAD/aspire-spring-2014.pdf|journal=Aspire|volume=1 |issue=1|pages=12}}
4. ^Mohamed Al-Kamel (MD), Odermatol.com. Retrieved 2015-02-09.
5. ^2013 EADV - ISD Specialty Meeting copy - International Society of Dermatology., Intsocderm.org. Retrieved 2015-02-09
6. ^International Society of Dermatology, Intsocderm.org.
7. ^1 [https://archive.today/20150210040034/http://www.stiefel.com/en/Pentostam.html Stiefel Supports Leishmaniasis Programme. RLCC programme: first steps towards eradication of the disease], Stiefel.com. Retrieved 2017-05-22.
8. ^{{Cite journal|last=Andersen|first=Louise K.|last2=Davis|first2=Mark D. P.|date=2017-04-23|title=A wake-up call to dermatologists - climate change affects the skin|journal=International Journal of Dermatology|volume=56|issue=10|pages=e198–e199|doi=10.1111/ijd.13617|issn=1365-4632|pmid=28436009}}
9. ^{{Cite journal|last=Andersen|first=Louise K.|last2=Davis|first2=Mark D. P.|title=A wake-up call to dermatologists – climate change affects the skin|journal=International Journal of Dermatology|volume=56|issue=10|language=en|pages=e198–e199|doi=10.1111/ijd.13617|pmid=28436009|issn=1365-4632|year=2017}}
10. ^1 {{Cite journal|last=Ahmed Al-Kamel|first=Mohamed|title=Feasibility of teledermatology in the eradication of leishmaniasis from Yemen project|url=http://oatext.com/Feasibility-of-teledermatology-in-the-eradication-of-leishmaniasis-from-Yemen-project.php|journal=Global Dermatology|language=en|volume=4|issue=2|doi=10.15761/god.1000206|year=2017}}
11. ^{{Cite web|url=https://drive.google.com/file/d/0B0OkRDJm7-COZUNZVlVtWURWMFk/view?usp=sharing&usp=embed_facebook|title=S_RLCC NEWSLETTER VOL 4 NO 1 SUMMER 2016 مجلة المركز الاقليمي لمكافحة الليشمانيا 4(1).pdf|last=|first=|year=2016|website=Google Docs|series=4(1)|publisher=RLCC|issn=2518-9875|access-date=2016-11-15}}
12. ^{{Cite web|url=https://drive.google.com/open?id=0B0OkRDJm7-COMDJaY0dOT1Y2ZjQ|title=YemenLeish |location=Yemen|date=2016–2017|issn=2518-9875}}
13. ^{{Cite journal|title = Leishmaniasis in Yemen: a clinicoepidemiological study of leishmaniasis in central Yemen|journal = International Journal of Dermatology|date = 2015-10-01|issn = 1365-4632|pages = 849–855|doi = 10.1111/ijd.13041|language = en|first = Mohamed A.|last = Al-Kamel|volume=55|issue = 8|pmid=26547479}}
14. ^{{Cite journal|last=Al-Kamel|first=Mohamed A.|date=2016-05-01|title=Spectrum of winter dermatoses in rural Yemen|journal=International Journal of Dermatology|language=en|volume=55|issue=5|pages=512–517|doi=10.1111/ijd.12886|pmid=26341716|issn=1365-4632}}
15. ^1 {{Cite journal|last=Al-Kamel|first=Mohamed A.|title=Impact of leishmaniasis in women: a practical review with an update on my ISD-supported initiative to combat leishmaniasis in Yemen (ELYP)|journal=International Journal of Women's Dermatology|volume=2|issue=3|pages=93–101|doi=10.1016/j.ijwd.2016.04.003|pmid=28492018|year=2016}}
16. ^{{Cite journal|last=Al-Kamel|first=Mohamed Ahmed|title=Stigmata in cutaneous leishmaniasis: Historical and new evidence-based concepts|url=http://www.odermatol.com/issue-in-html/2017-1-21-leishmaniasis/|journal=Our Dermatology Online|language=pl-PL|volume=8|issue=1|pages=81–90|doi=10.7241/ourd.20171.21|year=2017}}
17. ^{{Cite journal|last=Al-Kamel|first=Mohamed|date=July 2017|title=Cutaneous T Cell Lymphoma (CTCL) Superimposed on Disseminated Cutaneous Leishmaniasis (DCL) in an Immunocompromised Female from Yemen|url=http://scidoc.org/IJCDR-2332-2977-S3-002.php|journal=International Journal of Clinical Dermatology & Research|volume=S3-002|pages=|via=SciDoc}}
18. ^{{Cite journal|last=Al-Kamel|first=Mohamed Ahmed|title=Leishmaniasis and malignancy: A review and perspective|url=http://linkinghub.elsevier.com/retrieve/pii/S2405864517300684|journal=Clinical Skin Cancer|volume=2|issue=1–2|pages=54–58|doi=10.1016/j.clsc.2017.10.003|year=2017}}

External links

  • {{Official website|http://www.rlccye.org}}
  • {{Facebook|RLCCye}}
  • Blog
  • [https://www.youtube.com/c/RLCCyeorgRLCC Youtube]
  • Gallery
  • {{Twitter|RLCCyemen}}
{{DEFAULTSORT:Regional Leishmaniasis Control Center (RLCC)}}

2 : Medical and health organizations in Yemen|Leishmaniasis
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/9/20 21:18:32